Morphological predictors for low phenomenon after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction caused by plaque rupture

European Heart Journal Cardiovascular Imaging

Volumn 18, Issue 1, 2017, Pages 103-110

  Soeda, Tsunenari ^a   Higuma, Takumi ^b   Abe, Naoki ^b   Yamada, Masahiro ^b   Yokoyama, Hiroaki ^b   Shibutani, Shuji ^b   Ong, Daniel S ^a   Vergallo, Rocco ^a   Minami, Yoshiyasu ^a   Lee, Hang ^a   Okumura, Ken ^b   Jang, Ik Kyung ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HIROSAKI UNIVERSITY   (Japan)

^c Kyung Hee University   (South Korea)

Author keywords

Low; Optical coherence tomography; Plaque rupture; St segment elevation myocardial infarction

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; AREA UNDER THE CURVE; ARTICLE; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY RECANALIZATION; CORONARY IMAGING CATHETER; DYSLIPIDEMIA; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; NO REFLOW PHENOMENON; OPTICAL COHERENCE TOMOGRAPHY; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBUS ASPIRATION; TISSUE CHARACTERIZATION; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; COHORT ANALYSIS; COMPARATIVE STUDY; CORONARY ANGIOGRAPHY; DIAGNOSTIC IMAGING; HEART RUPTURE; INTERVENTIONAL ULTRASONOGRAPHY; MIDDLE AGED; MORTALITY; PATHOLOGY; PROCEDURES; PROGNOSIS; RISK ASSESSMENT; ST ELEVATION MYOCARDIAL INFARCTION; STATISTICAL MODEL; SURVIVAL ANALYSIS; UNIVERSITY HOSPITAL;

AGED; AREA UNDER CURVE; COHORT STUDIES; CORONARY ANGIOGRAPHY; FEMALE; HEART RUPTURE, POST-INFARCTION; HOSPITALS, UNIVERSITY; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NO-REFLOW PHENOMENON; PERCUTANEOUS CORONARY INTERVENTION; PLAQUE, ATHEROSCLEROTIC; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; ROC CURVE; ST ELEVATION MYOCARDIAL INFARCTION; SURVIVAL ANALYSIS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84985960249     PISSN: 20472404     EISSN: 20472412     Source Type: Journal    
DOI: 10.1093/ehjci/jev341     Document Type: Article

References (28)

1. Svilaas T, Vlaar PJ, van der Horst, IC, Diercks, GF, de Smet, BJ, van den Heuvel, AF et al. Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med 2008;358:557-67.
2. Carrick D, Oldroyd KG, McEntegart M, Haig C, Petrie MC, Eteiba H et al. A randomized trial of deferred stenting versus immediate stenting to prevent no- or slowreflow in acute ST-segment elevation myocardial infarction (DEFER-STEMI). J Am Coll Cardiol 2014;63:2088-98.
3. Ito H, Maruyama A, Iwakura K, Takiuchi S, Masuyama T, Hori M et al. Clinical implications of the 'low' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 1996;93:223-8.
4. Harrison RW, Aggarwal A, Ou FS, Klein LW, Rumsfeld JS, Roe MT et al. Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarction. Am J Cardiol 2013; 111:178-84.
5. Gibson CM, Cannon CP, Murphy SA, Marble SJ, Barron HV, Braunwald E. Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-Term outcomes after thrombolytic administration in acute myocardial infarction. Circulation 2002;105:1909-13.
6. Higuma T, Soeda T, Abe N, Yamada M, Yokoyama H, Shibutani S et al. A combined optical coherence tomography and intravascular ultrasound study on plaque rupture, plaque erosion, and calcified nodule in patients with ST-segment elevation myocardial infarction: incidence, morphologic characteristics, and outcomes after percutaneous coronary intervention. JACC Cardiovasc Interv 2015;8:1166-76.
7. Jia H, Abtahian F, Aguirre AD, Lee S, Chia S, Lowe H et al. In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography. J Am Coll Cardiol 2013;62:1748-58.
8. Hayashi T, Kiyoshima T, Matsuura M, Ueno M, Kobayashi N, Yabushita H et al. Plaque erosion in the culprit lesion is prone to develop a smaller myocardial infarction size compared with plaque rupture. Am Heart J 2005;149:284-90.
9. Endo M, Hibi K, Shimizu T, Komura N, Kusama I, Otsuka F et al. Impact of ultrasound attenuation and plaque rupture as detected by intravascular ultrasound on the incidence of no-reflow phenomenon after percutaneous coronary intervention in ST-segment elevation myocardial infarction. J Am Coll Cardiol Intv 2010;3: 540-9.
10. Iijima R, Shinji H, Ikeda N, Itaya H, Makino K, Funatsu A et al. Comparison of coronary arterial finding by intravascular ultrasound in patients with 'transient no-reflow' versus 'reflow' during percutaneous coronary intervention in acute coronary syndrome. Am J Cardiol 2006;97:29-33.
11. Katayama T, Kubo N, Takagi Y, Funayama H, Ikeda N, Ishida T et al. Relation of atherothrombosis burden and volume detected by intravascular ultrasound to angiographic no-reflow phenomenon during stent implantation in patients with acute myocardial infarction. Am J Cardiol 2006;97:301-4.
12. Hong YJ, Jeong MH, Choi YH, Ko JS, Lee MG, Kang WY et al. Impact of plaque components on no-reflow phenomenon after stent deployment in patients with acute coronary syndrome: A virtual histology-intravascular ultrasound analysis. Eur Heart J 2011;32:2059-66.
13. Kotani J, Mintz GS, Castagna MT, Berzingi CO, Pichard AD, Satler LF et al. Relation of plaque morphology to thrombolysis in myocardial infarction flow in acute myocardial infarction determined by intravascular ultrasound. Am J Cardiol 2003;91: 1096-9.
14. Tanaka A, Imanishi T, Kitabata H, Kubo T, Takarada S, Tanimoto T et al. Lipid-rich plaque and myocardial perfusion after successful stenting in patients with non-ST-segment elevation acute coronary syndrome: An optical coherence tomography study. Eur Heart J 2009;30:1348-55.
15. Jang IK, Tearney GJ, MacNeill B, Takano M, Moselewski F, IftimaNet al. In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation 2005;111:1551-5.
16. Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 1987;76:142-54.
17. Ribichini F, Wijns W, Ferrero V, Matullo G, Camilla T, Feola M et al. Effect of angiotensin-converting enzyme inhibition on restenosis after coronary stenting. Am J Cardiol 2003;91:154-8.
18. Early effects of tissue-Type plasminogen activator added to conventional therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest. Results of the Thrombolysis in Myocardial Ischemia (TIMI IIIA) Trial. Circulation 1993;87:38-52.
19. Niccoli G, Burzotta F, Galiuto L, Crea F. Myocardial no-reflow in humans. J Am Coll Cardiol 2009;54:281-92.
20. Di Vito, L, Yoon JH, Kato K, Yonetsu T, Vergallo R, Costa M et al. Comprehensive overview of definitions for optical coherence tomography-based plaque and stent analyses. Coron Artery Dis 2014;25:172-85.
21. Prati F, Regar E, Mintz GS, Arbustini E, Di Mario C, Jang IK et al. Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis. Eur Heart J 2010; 31:401-15.
22. Mintz GS, Nissen SE, Anderson WD, Bailey SR, Erbel R, Fitzgerald PJ et al. American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2001;37:1478-92.
23. Vancraeynest D, Pasquet A, Roelants V, Gerber BL, Vanoverschelde JL. Imaging the vulnerable plaque. J Am Coll Cardiol 2011;57:1961-79.
24. Fernandez-Ortiz A, Badimon JJ, Falk E, Fuster V, Meyer B, Mailhac A et al. Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. J Am Coll Cardiol 1994;23:1562-9.
25. Toda N. Age-related changes in endothelial function and blood flow regulation. Pharmacol Ther 2012;133:159-76.
26. De Luca, G, Suryapranata H, Stone GW, Antoniucci D, Neumann FJ, Chiariello M. Adjunctive mechanical devices to prevent distal embolization in patients undergoing mechanical revascularization for acute myocardial infarction: A meta-Analysis of randomized trials. Am Heart J 2007;153:343-53.
27. Lonborg J, Kelbaek H, Helqvist S, Holmvang L, Jorgensen E, Saunamaki K et al. The impact of distal embolization and distal protection on long-Term outcome in patients with ST elevation myocardial infarction randomized to primary percutaneous coronary intervention-results from a randomized study. Eur Heart J Acute Cardiovasc Care 2015;4:180-8.
28. Iwakura K, Ito H, Kawano S, Okamura A, Kurotobi T, Date M et al. Chronic pretreatment of statins is associated with the reduction of the no-reflow phenomenon in the patients with reperfused acute myocardial infarction. Eur Heart J 2006;27: 534-9.